Академический Документы
Профессиональный Документы
Культура Документы
Ozietta D. Taylor
To cite this article: Ozietta D. Taylor (2010) Predictors and Protective Factors in the Prevention
and Treatment of Adolescent Substance Use Disorders, Journal of Human Behavior in the
Social Environment, 20:5, 601-617, DOI: 10.1080/10911351003673369
Download by: [Universiti Teknologi Malaysia] Date: 21 June 2016, At: 21:12
Journal of Human Behavior in the Social Environment, 20:601–617, 2010
Copyright © Taylor & Francis Group, LLC
ISSN: 1091-1359 print/1540-3556 online
DOI: 10.1080/10911351003673369
OZIETTA D. TAYLOR
Department of Applied Psychology and Rehabilitation Counseling,
Coppin State University, Baltimore, Maryland
Downloaded by [Universiti Teknologi Malaysia] at 21:12 21 June 2016
INTRODUCTION
601
602 O. D. Taylor
at record rates; however, alcohol is not the primary drug of choice anymore.
Ecstasy is now the primary drug of choice (MFT, 2007).
The MTF study, consisting of a sample of more than 48,000 adolescents
in 403 secondary schools in the eighth, tenth, and twelfth grades indicated
that although marijuana, amphetamines, Ritalin, methamphetamine, crystal
methamphetamine, alcohol, and cigarettes use is decreasing gradually in
one grade cohort (eighth grade), ecstasy use is on the increase in adolescent
cohorts in the tenth and twelfth grades. Though the decrease in marijuana
and other substance use appears promising, because it was once viewed as
a gateway drug, practitioners cannot take the statistics lightly. For example,
in 2007, the annual prevalence of marijuana use fell by a significant 1.4
percentage points among eighth graders to 10.3% and by a non-significant
Downloaded by [Universiti Teknologi Malaysia] at 21:12 21 June 2016
0.6 percentage points among tenth graders to 24.6%, and annual marijuana
use among twelfth graders leveled at 31.7% (MTF, 2007).
Conversely, the other substances falling within a variety of drug classi-
fications showed little-to-no change in usage during 2007. These substances
included hallucinogens (i.e., LSD); cocaine and crack; heroin (and its deriva-
tives such as OxyContin and Vicodin); sedatives; tranquilizers; the ‘‘club
drugs’’ (i.e., Ketamine, Rohypnol, and GHB); and steroids. Conversely, though
the study did not focus on alcohol abuse, if included in the study the statistics
would soar. Furthermore, it has been reported in the MTF study that slightly
fewer than half of American secondary school students have tried alcohol
or other drugs (AOD) by the time they near high school graduation (MTF,
2007). Therefore, whether adolescents are experimenting with AOD or using
these substances on a regular basis, it is imperative that therapists gain an
understanding of the severity of adolescent substance abuse and dependence
to prevent or treat the onset of the substance use disorders. Thus, this article
seeks to educate readers of the predictors (i.e., risk factors), prosocial factors
(i.e., family bonding), and current paradigms in substance abuse prevention.
Further, the current treatment modalities (i.e., cognitive-behavioral therapy)
that are being utilized in treating substance-abusing or substance-dependent
adolescents will be identified.
or avoid the symptoms. Withdrawal symptoms will vary with the type of
substance taken. Physiological signs of withdrawal are common with alcohol,
opioids, sedatives, hypnotics, and anxiolytics. Further, withdrawal symptoms
are less apparent with amphetamines, cocaine, and hallucinogens.
Finally, the DSM-IV-TR describes the following as the compulsive pattern
of substance taking behavior (that is, behavior characteristic of substance
dependence):
1. The individual may take the substance in larger amounts or over a longer
period of time than was intended.
2. The individual may express a persistent desire to cut down or regulate
substance use.
Downloaded by [Universiti Teknologi Malaysia] at 21:12 21 June 2016
3. The individual may spend a great deal of time obtaining the substance,
using the substance, or recovering from its effects.
4. The individual’s activities revolve around the use of the substance.
5. The individual may withdraw from family activities and hobbies to use the
substance in private or to spend more time with substance using friends.
& Riggs, 1995), lower school motivation, school failures, emotional distress,
life dissatisfaction, depression, impulsiveness, restlessness, and little-to-no
church attendance (Adlaf & Smart, 1985; Crowley & Riggs, 1995).
Twenty-one years later, Lysaught and Wodarski (1996) found that the
early initiation of substance abuse include parental alcoholism, risk-taking
behaviors, peer group influence, deviant personality traits, low self-esteem,
and childhood or adolescent depression.
Almost 30 years after the study conducted by the Jessors, the National In-
stitute on Drug Abuse (NIDA, 2002) avowed that substance use is precipitated
by a chaotic home environment, parents who use or abuse substances, par-
ents with mental illnesses, ineffective parenting skills, children with difficult
temperaments, oppositional deviance or conduct disorders, lack of mutual
Downloaded by [Universiti Teknologi Malaysia] at 21:12 21 June 2016
quency, associating with negative peer groups, problems at home and in the
school setting, violent or aggressive behavior, oppositional deviance disorder
and conduct disorder, and engaging in risky sexual behavior (NIDA, 2003).
According to the NIDA (2003), families play a major role in their chil-
dren’s behavioral problems and their drug use patterns. Bronfenbrenner
(1977, 1979, 1986, 1988) recognized that a child develops within the context
of a variety of social systems. These social systems include the family, peers,
institutions, communities, and government. Although other systems influence
the lives of these youths, the family is the most important system in which
an adolescent learns and develops (Perrino, Gonzales-Soldevilla, Pantin, &
Szapoocznik, 2000; Szapocznik & Coatsworth, 1999).
Families of substance-abusing adolescents exhibit high degrees of neg-
ativity (Robbin, Szapocznik, Alexander, & Miller, 1998). Negativity is usu-
ally heightened when family members fight and blame one another for
an adolescent’s behavior. Communication between family members and the
adolescent is often emotionally charged and bitter, leading to a host of other
behavior issues. Some behaviors are linked to the poor quality of parent-
adolescent communication; the lack of clear rules and consequences or the
inconsistent application of rules and consequences for an adolescent’s be-
havior; inadequate monitoring and management of the adolescent activities
with peers; lack of adult supervision of the adolescent’s activities with peers;
poor adolescent bonding to family; and poor family cohesiveness (NIDA,
2003). Moreover, parents engaging in substance-using practices can have a
negative influence on adolescents living within the family system. Thus, the
substance-abusing behaviors manifested by some youths are learned through
the family system or their peer groups.
years of age (11.9%) lived with at least one parent who was dependent on
or abused alcohol or an illicit drug during the past year. Of the 8.3 million
children living with a substance abusing parent, 10.3% lived with a parent
who was dependent on or abused alcohol, and about 3% lived with a parent
who was dependent on or abused illicit drugs. Furthermore, approximately,
5.4 million children under 18 years of age lived with a father who met the
criteria for past year substance dependence or abuse, and 3.4 million lived
with a mother who met the criteria (USDUH). Extensive research has been
completed on the genetic factors in alcoholism (Duncan et al., 2006; NIAAA,
1992; Heath, 1994; Schuckit, 1995; Miles, 1995; Cotton, 1979). Though the
research focuses mainly on the genetic predisposition of alcoholism, it is
assumed that the results are applicable to the other drugs of abuse (McNeece
Downloaded by [Universiti Teknologi Malaysia] at 21:12 21 June 2016
Substance-Dependent Adolescents
Substance addiction and alcoholism form a progressive, chronic, complex but
treatable disease. It is characterized by compulsive drug craving, seeking, and
use persisting even in the face of severe adverse consequences. For many
people, substance addiction is chronic, with relapses possible even after
long periods of abstinence. In fact, relapse to substance abuse occurs at rates
similar to other chronic medical illnesses such as diabetes, hypertension, and
asthma (Fisher & Harrison, 2005). As with other chronic, recurring illnesses,
addiction is characterized by relapse and may require repeated treatments.
Through treatment, people with substance addiction can lead productive
lives.
The ultimate goal of substance-addiction treatment is to enable an indi-
vidual to achieve lasting abstinence, but the immediate goals are to reduce
substance abuse, improve a patient’s ability to function, and minimize the
medical and social complications of substance abuse and addiction. Like
people with diabetes or heart disease, people in treatment for substance
addiction will have to change their behavior to adopt a healthy lifestyle
(NIDA, 2002).
Several treatment approaches are utilized by treatment professionals in
helping adolescents with substance use disorders. These treatment modalities
include but are not limited to (1) Twelve Step Programs, (2) family therapy,
(3) cognitive-behavioral therapy, (4) psychopharmacology, and (5) relapse
prevention.
12 Step Programs show that abstinence rates for adolescents are at about
50% to 60% (SAMSHA, 1999).
FAMILY THERAPY
COGNITIVE-BEHAVIORAL THERAPY
PSYCHOPHARMACOLOGY
Psychopharmacology is the use of medication to treat substance use dis-
orders, in particular the substance dependence disorder. Pharmacological
agents are used in the detoxification, treatment, and withdrawal symptoms
of substance dependency. Disulfiram (Antabuse) is prescribed to deter al-
coholics from alcohol use. It causes an aversive, toxic reaction if alcohol is
ingested. The physical reaction of ingesting alcohol when Antabuse is taken
is very unpleasant. Hallucinations many occur in patients who ingest high
doses of Antabuse (i.e., more than 500 mg/day) (SAMHSA, 2005). Some of the
adverse effects resulting from Antabuse ingestion are drowsiness, depression,
disorientation, headache, restlessness, excitation, optic neuritis, periphereal
Predictors and Protective Factors 611
decrease alcohol craving and relapse potential. Further, this medication has
the ability to interfere with the management of pain when opioids are taken
(SAMHSA, 2005). Case studies report efficacy in mitigating hallucinogen-
related flashbacks. Side effects resulting from naltrexone use are abdom-
inal cramps, nausea, vomiting, weight loss, headache, insomnia, anxiety,
dysphoria, depression, confusion, nervousness, and joint and muscle pain
(Bezchlibnyk-Butler et al., 1999).
Buprenorphine, approved in 2002, is a prescription medication used to
treat opioid addiction. It has the dual purpose of treating opioid withdrawal
symptoms and long-term maintenance. Physicians can prescribe buprenor-
phine from their medical offices. The action of this medication is comparable
to methadone at low doses; however, it causes narcotic withdrawal at higher
doses (SAMHSA, 2005).
Bromocriptine and amantadine, medications used in the treatment of co-
caine, have been utilized to decrease cravings and dysphoria during cocaine
withdrawal (Giannini, Baumgartel, & DiMarzio, 1987; Tennant & Sagerian,
1987).
SUMMARY
REFERENCES
Adlaf, E. M., & Smart, R. G. (1985). Drug use and religious affiliation, feelings and
Downloaded by [Universiti Teknologi Malaysia] at 21:12 21 June 2016
Cook, C. H. (1988). The Minnesota Model in the management of drug and alcohol
dependency: Miracle or myth? Part I. Evidence and conclusion. British Journal
of Addiction, 83, 625–634.
Cotton, N. S. (1979). The familial incidence of alcoholism: A review. Journal of
Studies on Alcohol, 40, 89–116.
Crowley T. J., & Riggs, P. (1995). Adolescent substance use disorder with con-
duct disorder and comorbid conditions. In Adolescent drug abuse: Clinical
assessment and therapeutic interventions. National Institute on Drug Abuse
Research Monograph Series. Rockville, MD: U.S. Department of Health and
Human Services.
Cummings, C., Gordon, J. R., & Marlatt, G. A. (1980). Relapse: Strategies of prevention
and prediction. In W. R. Miller (Ed.), The addictive behaviors: Treatment of alco-
holism, drug abuse, smoking and obesity (pp. 291–321). New York: Pergamon
Downloaded by [Universiti Teknologi Malaysia] at 21:12 21 June 2016
Press.
Department of Health and Human Services. (1994). Technical Assistance Publication
Series 11: Treatment for Alcohol and Other Drug Abuse: Opportunities for
Coordination. Washington, DC: Author.
Dishion, T., Patterson, G. R., & Feid, J. R. (1988). Parent and peer factors associated
with drug sampling in early adolescence: Implications for treatment. NIDA
research monograph, 77, 69–93.
Doweiko, H. E. (2006). Concepts of chemical dependency (6th ed.). Florence, KY:
Thomson Brooks/Cole.
Duncan, A., Scherrer, J., Fu, Q., Bucholz, K., Health, A., True, W., et al. (2006).
Exposure to paternal alcoholism does not predict development of alcohol-use
disorders in offspring. Journal of Studies on Alcohol and Drugs, 67(5), 649–
656.
Estes, N. J. & Heinemann, M. E. (1986). Alcoholism: Development, consequences and
interventions. St. Louis: The C. V. Mosby Company.
Fassler, D. G., & Dumas, L. S. (1997). ‘‘Help Me, I’m Sad’’: Recognizing, treating and
preventing childhood and adolescent depression. New York: Penguin Book.
Fisher, G. L., & Harrison, T. C. (2005). Substance abuse: Information for school
counselors, social workers, therapist and counselors (2nd ed.). Boston: Allyn &
Bacon.
Giannini, A. J., Baumgartel, P., & Dimarzio, L. R. (1987). Bromocriptine therapy in
cocaine withdrawal. Journal of Clinical Pharmacology, 27, 267–270.
Goodwin, D. W., & Warnock, J. K. (1991). Alcoholism: A family disease. In R. J.
Frances & S. I. Miller (Eds.), Clinical Textbook of Addictive Disorders (pp. 485–
500). New York: Guilford.
Greene, G., MaCintyre, S., West, P., & Ecob, R. (1991). Like parent like child?
Associations between drinking and smoking behaviors of parents and their
children. British Journal of Addictions, 25, 495–511.
Haskin, D., Hatzenbuehler, M., & Waxman, R. (2006). Genetics of substance use
disorders. In W. Miller & K. M. Carroll (Eds.), Rethinking substance abuse:
What the science shows and what we can do about it (pp. 61–77). New York:
Guilford Press.
Heath, A. C., Martin, N. G. (1994). Genetic influences on alcohol consumption
patterns and problem drinking: Results from the Australian NH&MRC twin panel
follow–up survey. Annals of the New York Academy of Sciences, 708, 72–85.
Predictors and Protective Factors 615
Hogan, J. A., Gabrielsen, K. R., Luna, N., & Grothaus, D. (2003). Substance abuse
prevention: The intersection of science and practice. Upper Saddle River, NJ:
Pearson Education.
Jessor, R., & Jessor, S. (1977). Problem behavior and psychosocial development: A
longitudinal study of youth. New York: Academic Press.
Johnson Institute. (1996). Training families to do a successful intervention: a pro-
fessional guide. Minneapolis: Author.
Johnston, L. D., O’Malley, P. M., & Bachman, J. G. (2003). Monitoring the future na-
tional results on adolescent drug use: Overview of key findings, 2002. Bethesda,
MD: National Institute on Drug Abuse.
Johnston, L. D., O’Malley, P. M., Bachman, J. G., & Schulenberg, J. E. (2008).
Monitoring the future national results on adolescent drug use: Overview of
key findings, 2007. Bethesda, MD: National Institute on Drug Abuse.
Downloaded by [Universiti Teknologi Malaysia] at 21:12 21 June 2016
Technical Assistance Publication Series 11 (1994). Treatment for alcohol and other
drug abuse: Opportunities for coordination department of health and human
services. Publication No. (SMA) 94-2075.
Tennant, F. S., and Sagerian, A. A. (1987). Double-blind comparison of amanta-
dine and bromocriptine for ambulatory withdrawal from cocaine dependency.
Archives of Internal Medicine, 147, 109–112.
Thomas, C. S., & Schandler, S. L. (1996). Risk factors in adolescent substance abuse:
Treatment and management implications. Journal of Child and Adolescent Sub-
stance Abuse, 5(3) 1–16.
Wheeler, K., & Malmquist, J. (1987). Treatment approaches in adolescent chemical
dependency. Pediatric Clinics of North America, 34, 437–447.
Windle, M. (1994). Coexisting problems and alcoholic family risk among adolescents.
In T. F. Babor, V. M. Hesselbrock, R. E. Meyer, & W. Shoemaker (Eds.), Types
Downloaded by [Universiti Teknologi Malaysia] at 21:12 21 June 2016